We are live on ! Find out more
SP

Steelhead Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 0.01%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+0.01%
3 Year Est. Return
+0.04%
5 Year Est. Return
+0.04%
10 Year Est. Return
+4.69%
AUM
$1.17B
AUM Growth
-$289M
Cap. Flow
-$1.07B
Cap. Flow %
-92.14%
Top 10 Hldgs %
51.97%
Holding
41
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
CNMD icon
CONMED
CNMD
+$958K

Top Sells

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$106K

Sector Composition

Rank Sector Weight
1 Healthcare 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNMD icon
1
CONMED
CNMD
$1.24B
$764K 0.07%
+7,980
New +$958K
PGEN icon
2
Precigen
PGEN
$1.98B
– –
-50,000
Closed -$106K

Similar funds

HRES
Heitman Real Estate Securities Chicago, Illinois $1.39B AUM 6.59% 1-Year Est. Return
SRAIM
Scheer Rowlett & Associates Investment Management Toronto, Ontario, Canada $1.39B AUM 49.24% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.39B AUM 18.33% 1-Year Est. Return
TCC
Trans-Canada Capital Montreal, Quebec, Canada $1.39B AUM 16.61% 1-Year Est. Return
SC
Sagefield Capital Dallas, Texas $1.39B AUM 60.14% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return

Steelhead Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Steelhead Partners held 41 positions worth $1.17B, down 20% from $1.45B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Steelhead Partners withdrew a net $1.07B in Q2 2022, closing 1 position. Its most notable exit was Precigen, an estimated $106K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 0.07% of assets, up from 0.01% a quarter earlier.

Against the trend, Steelhead Partners opened a new position in CONMED worth $764K.

  • Steelhead Partners's largest Q2 2022 buy was CONMED: 7,980 shares worth $764K.
  • Steelhead Partners fully exited Precigen in Q2 2022, selling an estimated $106K.
  • Steelhead Partners's ten largest holdings make up 52% of its $1.17B portfolio in Q2 2022.
  • Steelhead Partners opened 1 new position and closed 1 in Q2 2022.
  • Steelhead Partners's portfolio value fell 20% quarter-over-quarter to $1.17B.

Based on Steelhead Partners's 13F filing for Q2 2022, filed 16 Aug 2022.